LNTH FY 2024 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena

LNTHLantheus Holdings, Inc.

$6B

FY 2024 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.5B+18.3% YoY

Gross Profit

$988M64.4% margin

Operating Income

$457M29.8% margin

Net Income

$312M20.4% margin

EPS (Diluted)

$4.36

Cash Flow

Operating Cash Flow

$545M

Free Cash Flow

$493M

Stock-Based Comp.

$76M

Balance Sheet

Total Assets

$2.0B

Total Liabilities

$892M

Stockholders' Equity

$1.1B

Cash & Equivalents

$913M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.5B	$1.3B	+18.3%
Gross Profit	$988M	$710M	+39.3%
Operating Income	$457M	$365M	+25.3%
Net Income	$312M	$327M	-4.4%